Anti-programmed death ligand 1 therapy-induced type 1 diabetes presenting with multiple islet-related autoantibodies.
Hisae HonokiKunimasa YagiKenta KambaraDaisuke ChujoMasataka ShikataAsako EnkakuAkiko Takikawa-NishidaJianhui LiuShiho FujisakaKazuyuki TobePublished in: Journal of diabetes investigation (2019)